Literature DB >> 3265424

Pituitary and adrenal response to ovine corticotropin-releasing hormone in women with polycystic ovarian syndrome.

A Mongioì1, M Macchi, E Vicari, M C Fornito, A E Calogero, C Riccioli, G Minacapilli, M L Moncada, R D'Agata.   

Abstract

It has been hypothesized that there is an adrenal abnormality in the polycystic ovary syndrome (PCO). This study was undertaken to examine this hypothesis in a more physiological way, by enhancing the ACTH secretion in response to ovine corticotropin releasing hormone (oCRH) injection so that adrenal androgen and glucocorticoid responsiveness to endogenous stimulation could be examined. Plasma ACTH and the ACTH and cortisol (F) response to oCRH were normal. The plasma T and dehydroepiandrosterone (DHEA) responses were also normal. The androstenedione (A) response, however, was exaggerated. This study supports the hypothesis that the adrenal gland in patients with PCO produces increased amounts of androstenedione in response to ACTH stimulation.

Entities:  

Mesh:

Substances:

Year:  1988        PMID: 3265424     DOI: 10.1007/BF03350202

Source DB:  PubMed          Journal:  J Endocrinol Invest        ISSN: 0391-4097            Impact factor:   4.256


  21 in total

1.  Adrenal function in hirsutism I. Diurnal change and response of plasma androstenedione, testosterone, 17-hydroxyprogesterone, cortisol, LH and FSH to dexamethasone and 1/2 unit of ACTH.

Authors:  J R Givens; R N Andersen; J B Ragland; W L Wiser; E S Umstot
Journal:  J Clin Endocrinol Metab       Date:  1975-06       Impact factor: 5.958

2.  Adrenal abnormalities in polycystic ovary syndrome.

Authors:  T Loughlin; S Cunningham; A Moore; M Culliton; P P Smyth; T J McKenna
Journal:  J Clin Endocrinol Metab       Date:  1986-01       Impact factor: 5.958

Review 3.  The polycystic ovary syndrome.

Authors:  S S Yen
Journal:  Clin Endocrinol (Oxf)       Date:  1980-02       Impact factor: 3.478

4.  Pulsatile administration of human corticotropin-releasing hormone in patients with secondary adrenal insufficiency: restoration of the normal cortisol secretory pattern.

Authors:  P C Avgerinos; T H Schürmeyer; P W Gold; T P Tomai; D L Loriaux; R J Sherins; G B Cutler; G P Chrousos
Journal:  J Clin Endocrinol Metab       Date:  1986-05       Impact factor: 5.958

5.  Synthetic ovine corticotropin-releasing hormone: simultaneous release of proopiolipomelanocortin peptides in man.

Authors:  R V Jackson; G S DeCherney; C R DeBold; W R Sheldon; A N Alexander; J Rivier; W Vale; D N Orth
Journal:  J Clin Endocrinol Metab       Date:  1984-04       Impact factor: 5.958

6.  Elevated plasma levels of beta-endorphin in a group of women with polycystic ovarian disease.

Authors:  F A Aleem; T McIntosh
Journal:  Fertil Steril       Date:  1984-11       Impact factor: 7.329

7.  Pituitary-ovarian relationships in polycystic ovary syndrome.

Authors:  D T Baird; C S Corker; D W Davidson; W M Hunter; E A Michie; P F Van Look
Journal:  J Clin Endocrinol Metab       Date:  1977-10       Impact factor: 5.958

8.  Corticotropin-releasing factor: pharmacokinetics in man.

Authors:  H M Schulte; G P Chrousos; J D Booth; E H Oldfield; P W Gold; G B Cutler; D L Loriaux
Journal:  J Clin Endocrinol Metab       Date:  1984-01       Impact factor: 5.958

9.  beta-Endorphin and beta-lipotropin plasma levels in hirsute women: correlation with body weight.

Authors:  J R Givens; E Wiedemann; R N Andersen; A E Kitabchi
Journal:  J Clin Endocrinol Metab       Date:  1980-05       Impact factor: 5.958

10.  Maintenance of normal circulating levels of delta 4-androstenedione and dehydroepiandrosterone in simple obesity despite increased metabolic clearance rates: evidence for a servo-control mechanism.

Authors:  B R Kurtz; J R Givens; S Komindr; M D Stevens; J G Karas; J B Bittle; D Judge; A E Kitabchi
Journal:  J Clin Endocrinol Metab       Date:  1987-06       Impact factor: 5.958

View more
  1 in total

Review 1.  Role of Lipotoxicity and Contribution of the Renin-Angiotensin System in the Development of Polycystic Ovary Syndrome.

Authors:  Alexandre Connolly; Samuel Leblanc; Jean-Patrice Baillargeon
Journal:  Int J Endocrinol       Date:  2018-06-03       Impact factor: 3.257

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.